#VP1-001

[amcrasto]

VP1-001

VP1-001 CAS 2140-46-7 Cholest-5-ene-3,25-diol, (3β)-Molecular Weight, 402.65, C27 H46 O2 Cholest-5-ene-3β,25-diol (8CI)(3β)-Cholest-5-ene-3,25-diol25-Hydroxy-5-cholestene-3β-ol25-Hydroxycholesterol5-Cholesten-3β,25-diol Compound 29 – ViewPoint Therapeutics Originator University of California at San Francisco; University of Michigan; University of WashingtonDeveloper University of California…

[dailyhantnews]

मोतियाबिंद के लिए ड्रग थेरेपी एक कदम और करीब आती है

मोतियाबिंद के लिए ड्रग थेरेपी एक कदम और करीब आती है

प्रयोगशाला परीक्षणों में, ऑक्सीस्टेरॉल यौगिक VP1-001 के साथ उपचार ने अपवर्तक सूचकांक प्रोफ़ाइल में सुधार दिखाया – 61% लेंस में उच्च ध्यान केंद्रित करने की क्षमता बनाए रखने के लिए आवश्यक एक प्रमुख ऑप्टिकल पैरामीटर। इसका मतलब है कि लेंस की प्रोटीन संरचना को बहाल किया जा रहा है, जिसके परिणामस्वरूप लेंस बेहतर ध्यान केंद्रित करने में सक्षम है। यह 46% मामलों में लेंस अपारदर्शिता में कमी द्वारा समर्थित…

[indianfitnesscare]

Drug Therapy for Cataracts Heads a Step Closer

Drug Therapy for Cataracts Heads a Step Closer

A team of international scientists, led by Professor Barbara Pierscionek, Deputy Dean in the Faculty of Health, Education, Medicine and Social Care at Anglia Ruskin University (ARU), have been carrying out advanced optical tests on an oxysterol compound that had been proposed as an anti-cataract drug. In laboratory trials, treatment with the oxysterol compound VP1-001 showed an improvement in…

[indianfitnesscare]

Drug Therapy for Cataracts Heads a Step Closer

Drug Therapy for Cataracts Heads a Step Closer

A team of international scientists, led by Professor Barbara Pierscionek, Deputy Dean in the Faculty of Health, Education, Medicine and Social Care at Anglia Ruskin University (ARU), have been carrying out advanced optical tests on an oxysterol compound that had been proposed as an anti-cataract drug. In laboratory trials, treatment with the oxysterol compound VP1-001 showed an improvement in…